Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Durand

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Annals of Intensive Care|July 14, 2021
Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot studyClémence Marais, Caroline Claude, Nada Semaan, et al.
Molecules (Basel, Switzerland)|July 28, 2022
Cytotoxic and Antioxidant Activities of Imine Analogs of Trans-Resveratrol towards Murine Neuronal N2a CellsMohamed Ksila, Anne Vejux, Emmanuelle Prost-Camus, et al.
Life Sciences|October 11, 2011
Discovery of cytotoxic and pro-apoptotic compounds against leukemia cells: Tert-butyl-4-[(3-nitrophenoxy) methyl]-2,2-dimethyloxazolidine-3-carboxylateMauro C X Pinto, Danielle F Dias, Helen L Del Puerto, et al.
Plos One|August 23, 2012
Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary studyPascaline Boudou-Rouquette, Céline Narjoz, Jean Louis Golmard, et al.
Clinical Nutrition ESPEN|September 7, 2024
Relationship between energetic gap and sensitivity to anti-programmed cell death 1 immune checkpoint inhibitors in non-small cell lung cancer patients: The ELY-2 studyManuela Tiako Meyo, Pascaline Boudou-Rouquette, Jennifer Arrondeau, et al.
Pharmaceutical Research|June 22, 2011
Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patientsMichel Tod, Olivier Mir, Natacha Bancelin, et al.
Klinische Padiatrie|August 29, 2018
Differences of Medical Care for Acute Severe Viral Bronchiolitis in Two Urban Areas in EuropeChristian Dohna-Schwake, Katrin Mücher, Florian Stehling, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 11, 2022
Energy expenditure profiles and the risk of early limiting toxicity in older patients with cancer: The ELCAPA-25 prospective cohort surveyPascaline Boudou-Rouquette, Alexandre de Moura, Claudia Martinez-Tapia, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2021
Evaluation of borinic acids as new, fast hydrogen peroxide-responsive triggersBlaise Gatin-Fraudet, Roxane Ottenwelter, Thomas Le Saux, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|March 6, 2018
Malnutrition in Patients With Cancer: Comparison of Perceptions by Patients, Relatives, and Physicians-Results of the NutriCancer2012 StudyEmmanuel Gyan, Bruno Raynard, Jean-Philippe Durand, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Annals of Intensive Care|July 14, 2021
Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot studyClémence Marais, Caroline Claude, Nada Semaan, et al.
Molecules (Basel, Switzerland)|July 28, 2022
Cytotoxic and Antioxidant Activities of Imine Analogs of Trans-Resveratrol towards Murine Neuronal N2a CellsMohamed Ksila, Anne Vejux, Emmanuelle Prost-Camus, et al.
Life Sciences|October 11, 2011
Discovery of cytotoxic and pro-apoptotic compounds against leukemia cells: Tert-butyl-4-[(3-nitrophenoxy) methyl]-2,2-dimethyloxazolidine-3-carboxylateMauro C X Pinto, Danielle F Dias, Helen L Del Puerto, et al.
Plos One|August 23, 2012
Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary studyPascaline Boudou-Rouquette, Céline Narjoz, Jean Louis Golmard, et al.
Clinical Nutrition ESPEN|September 7, 2024
Relationship between energetic gap and sensitivity to anti-programmed cell death 1 immune checkpoint inhibitors in non-small cell lung cancer patients: The ELY-2 studyManuela Tiako Meyo, Pascaline Boudou-Rouquette, Jennifer Arrondeau, et al.
Pharmaceutical Research|June 22, 2011
Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patientsMichel Tod, Olivier Mir, Natacha Bancelin, et al.
Klinische Padiatrie|August 29, 2018
Differences of Medical Care for Acute Severe Viral Bronchiolitis in Two Urban Areas in EuropeChristian Dohna-Schwake, Katrin Mücher, Florian Stehling, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 11, 2022
Energy expenditure profiles and the risk of early limiting toxicity in older patients with cancer: The ELCAPA-25 prospective cohort surveyPascaline Boudou-Rouquette, Alexandre de Moura, Claudia Martinez-Tapia, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2021
Evaluation of borinic acids as new, fast hydrogen peroxide-responsive triggersBlaise Gatin-Fraudet, Roxane Ottenwelter, Thomas Le Saux, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|March 6, 2018
Malnutrition in Patients With Cancer: Comparison of Perceptions by Patients, Relatives, and Physicians-Results of the NutriCancer2012 StudyEmmanuel Gyan, Bruno Raynard, Jean-Philippe Durand, et al.
Pageof 18